Variable | Total population | Females | Males | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95%CI | p-value | HR | 95%CI | p-value | HR | 95%CI | p-value | |
Age | 1.18 | 1.11–1.26 | < 0.0001 | 1.17 | 1.05–1.31 | 0.005 | 1.22 | 1.12–1.32 | < 0.0001 |
IHD | 1.33 | 0.79–2.24 | 0.29 | 1.85 | 0.70–4.88 | 0.21 | 0.93 | 0.48–1.82 | 0.84 |
Hypertension | 1.26 | 0.74–2.16 | 0.40 | 2.10 | 0.75–5.86 | 0.16 | 1.23 | 0.66–2.29 | 0.52 |
Diabetes | 1.21 | 0.76–1.92 | 0.41 | 2.06 | 0.90–4.73 | 0.09 | 0.84 | 0.48–1.48 | 0.55 |
AECI/ARB | 1.03 | 0.63–1.70 | 0.91 | 0.65 | 0.26–1.63 | 0.36 | 1.29 | 0.70–2.38 | 0.41 |
Beta blockers | 0.75 | 0.46–1.24 | 0.26 | 0.61 | 0.27–1.42 | 0.25 | 0.73 | 0.38–1.39 | 0.33 |
Atrial fibr. | 2.02 | 1.11–3.66 | 0.02 | 4.72 | 1.60–13.92 | 0.005 | 1.83 | 0.91–3.67 | 0.09 |
Hb < 120 g/L | 1.55 | 0.86–2.79 | 0.14 | 3.70 | 1.52–9.00 | 0.004 | 1.10 | 0.48–2.54 | 0.82 |
EF < 40% | 1.77 | 0.93–3.37 | 0.08 | 3.12 | 0.82–11.85 | 0.09 | 1.62 | 0.72–3.66 | 0.24 |
TSP-1 rs2228262, A/A | 1.48 | 0.80–2.75 | 0.21 | 7.12 | 1.11–45.78 | 0.04 | 1.14 | 0.59–2.23 | 0.69 |